All News ZIVO Bioscience, Inc.

Equities

ZIVO

US98978N3098

Delayed OTC Markets Other stock markets 01:24:41 2024-04-29 pm EDT			5-day change	1st Jan Change
6.55 ^USD	-19.14%		-18.12%	+445.83%

Mar. 15	ZIVO Bioscience, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Feb. 07	ZIVO Bioscience, Inc. Reports Additional Findings from Positive 42-Day Coccidiosis Challenge Study	CI

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

ZIVO Bioscience, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 15	CI
ZIVO Bioscience Reports Additional Findings from Positive 42-Day Coccidiosis Challenge Study	Feb. 07	BU
ZIVO Bioscience, Inc. Reports Additional Findings from Positive 42-Day Coccidiosis Challenge Study	Feb. 07	CI
ZIVO Bioscience Announces Uplisting to OTCQB Market	Jan. 29	BU
Zivo Bioscience Reports Positive Efficacy Results from 42-Day Validation Study with Non-Antibiotic Immune-Modulating Product for the Prevention and Treatment of Coccidiosis in Broiler Chickens	Jan. 23	CI
ZIVO Bioscience, Inc. announced that it has received $0.531142 million in funding	Jan. 15	CI
ZIVO Bioscience, Inc. announced that it expects to receive $0.531142 million in funding	Jan. 03	CI
ZIVO Bioscience, Inc. announced that it has received $0.308936 million in funding	Dec. 26	CI
ZIVO Bioscience, Inc. announced that it expects to receive $0.308936 million in funding	Dec. 11	CI
ZIVO Bioscience, Inc. announced that it has received $0.2 million in funding	Dec. 04	CI
ZIVO Bioscience, Inc.(NasdaqCM:ZIVO) dropped from S&P TMI Index	Nov. 29	CI
ZIVO Bioscience, Inc.(OTCPK:ZIVO) dropped from NASDAQ Composite Index	Nov. 24	CI
ZIVO Bioscience, Inc. announced that it expects to receive $0.15 million in funding	Nov. 15	CI
ZIVO Bioscience, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 13	CI
Zivo Bioscience Insider Bought Shares Worth $199,600, According to a Recent SEC Filing	23-10-30	MT
ZIVO Bioscience Initiates 42-Day Validation Study with Immune-Modulating Product for the Prevention and Treatment of Coccidiosis in Broiler Chickens	23-10-30	BU
Reverse Split: 1 of 6	23-10-26	FA
ZIVO Bioscience Announces Reverse Stock Split	23-10-26	BU
ZIVO Bioscience : Dawon James Small Cap Growth Conference Presentation	23-10-12	PU
ZIVO Bioscience to Present at the Dawson James Small Cap Growth Conference	23-10-03	GL

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News ZIVO Bioscience, Inc.

Equities

ZIVO

US98978N3098

All News

Filters